Contineum fails in depression Read in browser

Thank you for reading, dupa dupackia! basic Subscription UPGRADE

M Tue W Th F 15 September, 2026

Real innovation is getting harder to spot. The Endpoints 11 is our read on the private companies clearing a rising bar, revealed at a gala dinner with the founders, investors and editors behind the list. Save on your gala pass with code ELEVEN26.

presented by Pac­ing the Jour­ney: A Frame­work to Com­mer­cial Readi­ness

news GSK strikes deal for Chimagen’s T cell engager for blood cancer Contineum, J&J's drug fails in mid-stage depression trial Exclusive: RegCell gets $66M boost to take Nobel-winning Tregs into clinic Vera eyes full approval for Trutakna in IgAN following positive readout

Sep 16 2:00 pm ET Beyond ICD codes: Unlocking rare disease insights with genomics and claims-based data sponsored by GeneDx Sep 22 12:00 pm ET The future of drug pricing: Medicare negotiation, MFN models & beyond sponsored by ADVI Oct 15 1:00 pm ET Insights into Polycystic Kidney Disease: The Potential of Clinicogenomic Data sponsored by Natera Oct 20 11:00 am ET Intelligent oversight and orchestration: How mission control is redefining R&D decision-making sponsored by ZS Oct 22 11:00 am ET A new model for clinical research – Expanding community trial access sponsored by Parexel

The entire healthcare ecosystem is more Silicon Valley-ified than ever before. What tech has actually changed? Is biopharma behind? Find out, join us for Health Tech day.

in case you missed it 1. BioNTech spells out survival win for gotistobart ahead of pivotal readout 2. AstraZeneca’s next-gen SERD disappoints in untreated advanced breast cancer 3. Akeso details survival win for its PD-1xVEGF drug versus Keytruda  4. GSK seeks to expand use of Nuvalent lung cancer drug with new data 5. Seeking a fresh start, Novo drops the 'Nordisk' 6. News Briefing Electra aims for nearly $300M IPO; Enhertu's Phase 3 lung cancer success 7. One state’s battle to stop people from taking unapproved weight-loss drugs 8. U.S. health officials move quickly to deploy medical A.I. despite concerns